Swahili
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Evolution of Effectiveness of Diabetes Medical Care in Russia

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
Kiungo kimehifadhiwa kwenye clipboard
HaliImekamilika
Wadhamini
Endocrinology Research Centre, Moscow

Maneno muhimu

Kikemikali

The main aim of the present study is to evaluate the prevalence of individual microvascular and macrovascular complications among diabetes mellitus patients and to determine the percentage of diabetes mellitus patients achieved HbA1c<7,0%.

Maelezo

Rationale for this Study Primary Existing routine health statistics underestimates the rate of morbidity due to diabetes complications. To provide more realistic estimation of morbidity, repeated epidemiological studies are essential in assessment of tendencies in diabetes medical care at the country level. They allow to reveal issues, which, being resolved, can contribute to the improvement of diabetes medical care effectiveness. Guidelines developed with this study data may save healthcare budgets and prevent financial losses due to diabetes-related morbidity and disability.

Objectives of the Study • Primary objective: To determine the prevalence of individual microvascular and macrovascular complications among patients with diabetes mellitus type 1 and type 2

• Secondary objective: To determine the percentage of patients with diabetes mellitus type 1 and type 2 achieved HbA1c <7,0%.

Study design The hired medical team (9 specialists) is going to perform the technical study-related tasks in Moscow Region.

Target population includes approximately 147,000 diabetes mellitus patients included in Regional Diabetes Mellitus Register, from which patients will be selected via random sampling (600 patients).

A special rented medical bus will accommodate the study personnel at the place and all the local study-related activities.

After obtaining a written Informed Consent Form by local endocrinologist the each study subject will have one study visit, when he or she should appear fasting and the following data will be collected, tests and examination performed:

- date of the diagnosis of type 1 or type 2 diabetes mellitus;

- medical history including coronary heart disease, myocardial infarction, coronary revascularization, cerebrovascular disease (ischaemic stroke, a transient ischemic attack), peripheral artery disease, diabetic retinopathy (type, stage, year of diagnosis), diabetic neuropathy, chronic kidney disease, diabetic foot;

- blood tests for HbA1c, serum total cholesterol, triglycerides, HDL- cholesterol, serum creatinine and estimation estimated Glomerular filtration rate by standard CKD-EPI, alanine-aminotransferase, aspartate-aminotransferase;

- urine analysis for albumin in spot urine;

- measurement of height, weight/BMI;

- measurement of sitting blood pressure, Electocardiogramm;

- eye examination, including fundoscopy;

- foot examination, including tests for touch, pain, temperature, and vibration sensation of the toes and mini-doppler ultrasound vessel study;

- current pharmacological therapy regimen (medications, daily doses). The medical team will admit up to 35 study subjects per day. This study has descriptive character. There is no any comparison to be performed.

Tarehe

Imethibitishwa Mwisho: 03/31/2016
Iliyowasilishwa Kwanza: 12/17/2014
Uandikishaji uliokadiriwa Uliwasilishwa: 10/08/2015
Iliyotumwa Kwanza: 10/11/2015
Sasisho la Mwisho Liliwasilishwa: 04/04/2016
Sasisho la Mwisho Lilichapishwa: 04/05/2016
Tarehe halisi ya kuanza kwa masomo: 07/31/2015
Tarehe ya Kukamilisha Msingi iliyokadiriwa: 09/30/2015
Tarehe ya Kukamilisha Utafiti: 09/30/2015

Hali au ugonjwa

Diabetes Mellitus, Type 2
Diabetes Mellitus, Type 1

Awamu

-

Vigezo vya Kustahiki

Zama zinazostahiki Kujifunza 18 Years Kwa 18 Years
Jinsia Inastahiki KujifunzaAll
Njia ya sampuliNon-Probability Sample
Hupokea Wajitolea wa AfyaNdio
Vigezo

Inclusion criteria:

The subject population for this study must meet the following criteria:

1. Provision of singed subject informed consent

2. Type 1 and type 2 diabetes mellitus Target population includes approximately 147,000 diabetes mellitus patients included in Regional DM Register, from which patients will be selected via random sampling (600 patients).

The prescription of the medicinal product is clearly separated from the decision to include the subject in the study.

Exclusion criteria:

1. Diagnosis of gestational diabetes mellitus alone.

Matokeo

Hatua za Matokeo ya Msingi

1. Percentage of patients with diabetes mellitus type 1 and type 2diabetes mellitus complications [30 days]

macrovascular complications, i.e. with history of chronic heart disease myocardial infarction ischaemic stroke transient ischemic attack any revascularization procedure any peripheral atherosclerosis e) microvascular complications, i.e. diabetic retinopathy diabetic neuropathy albuminuria chronic kidney disease stage f) other complications diagnosed after diabetes mellitus has been established, i.e. foot examination findings

Hatua za Matokeo ya Sekondari

1. The percentage of patients with diabetes mellitus type 1 and type 2 achieved HbA1c <7% [30 days]

2. Structure of antidiabetic therapy (% insulin, % OAD mono, % OAD dual, % OAD triple) [30 days]

Jiunge na ukurasa
wetu wa facebook

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

  • Inafanya kazi katika lugha 55
  • Uponyaji wa mitishamba unaungwa mkono na sayansi
  • Kutambua mimea kwa picha
  • Ramani ya GPS inayoshirikiana
  • Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
  • Tafuta mimea ya dawa na athari zao
  • Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa

Google Play badgeApp Store badge